SL Science Holding Ltd
SLBT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002070534
No open-market purchases or sales by SL Science Holding Ltd insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding SL Science Holding Ltd changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 579.9K | +579.9K |
| Value | $0 | $2.78M | +$2.78M |
New holders (9)
Institutions that held SL Science Holding Ltd at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 193,404 | $926.4K | 0.00% |
| L1 Global Manager Pty Ltd | 150,000 | $718.5K | 0.58% |
| Rivernorth Capital Management, LLC | 130,000 | $622.7K | 0.03% |
| SkyView Investment Advisors, LLC | 42,042 | $201.0K | 0.16% |
| Heights Capital Management, Inc | 20,000 | $95.8K | 0.02% |
| Lynx Capital Group Ltd | 17,096 | $81.9K | 0.03% |
| Jane Street Group, LLC | 14,540 | $69.6K | 0.00% |
| UBS Group AG | 12,515 | $59.9K | 0.00% |
| Advisor Group Holdings, Inc. | 286 | $1.37K | 0.00% |
Sold out (0)
Institutions that held SL Science Holding Ltd at the end of Q1 2026 and filed for Q2 2026 without it.
None.